BACKGROUND: Parkinson's disease (PD) is frequently complicated by co-occurring psychiatric problems such as depression and anxiety that negatively affect the course and management of the illness. Yet, in most cases, these psychiatric comorbidities are neither recognized nor treated to remission. The primary purpose of this study was to identify and describe barriers to mental health care utilization for people with PD. Secondary objectives included the assessment of attitudes and preferences regarding the need for mental health services in the PD community and the acceptability of telehealth interventions as a method for improving access and quality of care. METHODS: A total of 769 people with PD completed an anonymous cross-sectional questionnaire assessing barriers to mental health care utilization in this medical population. Respondents were drawn from a national sample. RESULTS: Commonly endorsed barriers to mental health care utilization in PD reflect the patients' incomplete understanding of mental health problems, access issues, and illness-specific concerns, as well as the inadequate screening and detection of psychiatric complications by medical providers and the need for more effective treatments in this medical population. Several demographic, medical, and psychiatric variables also influenced the likelihood of accessing mental health care. Interest in telehealth approaches to mental health treatment was high and, in several instances, correlated with perceived barriers to mental health care utilization. CONCLUSIONS: People with PD may encounter a multitude of barriers that impede their pursuit of mental health care. Clinical implications are discussed and further research is needed to replicate and extend these findings.
BACKGROUND:Parkinson's disease (PD) is frequently complicated by co-occurring psychiatric problems such as depression and anxiety that negatively affect the course and management of the illness. Yet, in most cases, these psychiatric comorbidities are neither recognized nor treated to remission. The primary purpose of this study was to identify and describe barriers to mental health care utilization for people with PD. Secondary objectives included the assessment of attitudes and preferences regarding the need for mental health services in the PD community and the acceptability of telehealth interventions as a method for improving access and quality of care. METHODS: A total of 769 people with PD completed an anonymous cross-sectional questionnaire assessing barriers to mental health care utilization in this medical population. Respondents were drawn from a national sample. RESULTS: Commonly endorsed barriers to mental health care utilization in PD reflect the patients' incomplete understanding of mental health problems, access issues, and illness-specific concerns, as well as the inadequate screening and detection of psychiatric complications by medical providers and the need for more effective treatments in this medical population. Several demographic, medical, and psychiatric variables also influenced the likelihood of accessing mental health care. Interest in telehealth approaches to mental health treatment was high and, in several instances, correlated with perceived barriers to mental health care utilization. CONCLUSIONS:People with PD may encounter a multitude of barriers that impede their pursuit of mental health care. Clinical implications are discussed and further research is needed to replicate and extend these findings.
Entities:
Keywords:
Parkinson’s disease; anxiety; barriers; depression; mental health care utilization
Authors: E Ray Dorsey; Lisa M Deuel; Tiffini S Voss; Kara Finnigan; Benjamin P George; Sheelah Eason; David Miller; Jason I Reminick; Anna Appler; Joyce Polanowicz; Lucy Viti; Sandy Smith; Anthony Joseph; Kevin M Biglan Journal: Mov Disord Date: 2010-08-15 Impact factor: 10.338
Authors: Roseanne D Dobkin; Matthew Menza; Lesley A Allen; Michael A Gara; Margery H Mark; Jade Tiu; Karina L Bienfait; Jill Friedman Journal: Am J Psychiatry Date: 2011-06-15 Impact factor: 18.112
Authors: Roseanne D Dobkin; Matthew Menza; Lesley A Allen; Jade Tiu; Jill Friedman; Karina L Bienfait; Michael A Gara; Margery H Mark Journal: J Geriatr Psychiatry Neurol Date: 2011-12 Impact factor: 2.680
Authors: I H Richard; M P McDermott; R Kurlan; J M Lyness; P G Como; N Pearson; S A Factor; J Juncos; C Serrano Ramos; M Brodsky; C Manning; L Marsh; L Shulman; H H Fernandez; K J Black; M Panisset; C W Christine; W Jiang; C Singer; S Horn; R Pfeiffer; D Rottenberg; J Slevin; L Elmer; D Press; H C Hyson; W McDonald Journal: Neurology Date: 2012-04-11 Impact factor: 9.910
Authors: Daniel Weintraub; Paul J Moberg; John E Duda; Ira R Katz; Matthew B Stern Journal: J Geriatr Psychiatry Neurol Date: 2003-09 Impact factor: 2.680
Authors: Jin-Mann S Lin; Dana J Brimmer; Roumiana S Boneva; James F Jones; William C Reeves Journal: BMC Health Serv Res Date: 2009-01-20 Impact factor: 2.655
Authors: Danielle S Abraham; Thanh Phuong Pham Nguyen; Sean Hennessy; Shelly L Gray; Dawei Xie; Daniel Weintraub; Allison W Willis Journal: Am J Geriatr Psychiatry Date: 2020-05-18 Impact factor: 4.105
Authors: S Landau; V Harris; D J Burn; J V Hindle; C S Hurt; M Samuel; K C Wilson; R G Brown Journal: Psychol Med Date: 2015-10-23 Impact factor: 7.723
Authors: Roseanne D Dobkin; Sarah L Mann; Michael A Gara; Alejandro Interian; Kailyn M Rodriguez; Matthew Menza Journal: Neurology Date: 2020-04-01 Impact factor: 9.910